Halogenated artemisinin mother nucleus, halogenated artemisinin derivatives, halogenated dihydroartemisinin and halogenated decarbonylation artemisinin and medical use thereof
A technology of artemisinin derivatives and dihydroartemisinin, which is applied in pharmaceutical formulations, medical preparations containing active ingredients, antibacterial drugs, etc., to achieve the effect of improving the treatment situation and rapid treatment effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0102] Dosage content
[0103] The oral dosage forms mentioned include: drop pills, quick-release drop pills, capsules, granules, sprays, oral
[0104] Liquid, tablet, powder (powder), ointment, etc.; matrix sustained-release preparations include: (1) insoluble (such as ethyl cellulose EC, polyethylene, polypropylene, polysiloxane, ethylene-vinyl acetate copolymer, (polymethyl methacrylate, etc.); (2) waxy skeleton (such as fat, waxy substances, stearic acid, stearyl alcohol, glyceryl monostearate, carnauba wax, stearyl alcohol, etc. ); (3) Hydrophilic gel (such as CMC, CMC-Na, MC, PVA, HEC, HCMC, sodium alginate, pectin, alginate, agar, hydroxypropyl methylcellulose HPMC, deacetylated shell polysaccharide, chitin, galactomannan, etc.); (4) gastric retention tablets, etc.; sustained-release coating preparations include (1) membrane-controlled release tablets, (2) microporous membrane-coated tablets, (3) small tablets Pills include: film-controlled pellets, skeleton pe...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 